Astellas Pharma Inc. (ALPMF)

Astellas Pharma had revenue of 505.79B JPY in the quarter ending June 30, 2025, with 6.91% growth. This brings the company's revenue in the last twelve months to 1.94T, up 14.29% year-over-year. In the fiscal year ending March 31, 2025, Astellas Pharma had annual revenue of 1.91T with 19.25% growth.

• Revenue (ttm): 1,944.99B JPY
• Revenue Growth: +14.29%
• P/S Ratio: 1.41
• Revenue / Employee: 142.56M JPY
• Employees: 13,643
• Market Cap: 19.05B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1,912.32B	308.65B	19.25%
Mar 31, 2024	1,603.67B	85.05B	5.60%
Mar 31, 2023	1,518.62B	222.46B	17.16%
Mar 31, 2022	1,296.16B	46.64B	3.73%
Mar 31, 2021	1,249.53B	-51.32B	-3.94%